Newronika
Pre-clinicalNewronika develops adaptive deep brain stimulation systems that respond to the brain's own signals. CE-marked αDBS therapy — precision neuromodulation for Parkinson's and beyond.
Founded
2016
Focus
NeuroscienceMedical Devices
About
Newronika develops adaptive deep brain stimulation systems that respond to the brain's own signals. CE-marked αDBS therapy — precision neuromodulation for Parkinson's and beyond.
Funding History
2Total raised: $12.5M
Grant$2.5MEuropean CommissionJun 15, 2021
Series A$10MPanakes PartnersJun 15, 2020
Company Info
TypePrivate
Founded2016
LocationMilan, Italy
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Pre-clinical · Milan
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile